FTC Commissioners yet to meet on Amgen-Horizon deal – CNBC

FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco

(Reuters) – Commissioners at the U.S. Federal Trade Commission (FTC) have not yet met to discuss Amgen’s acquisition of Horizon Therapeutics, CNBC reported on Tuesday.

The news comes a day after reports that the FTC is expected to file a lawsuit as early as Tuesday to block the $27.8 billion deal.

(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)

Related posts

Spirit Christmas expands New Jersey holiday pop-ups with new 2025 locations including Toms River

Flight attendant age discrimination suit moves forward in New Jersey court against United Airlines

Judge tosses inmate’s civil rights suit against Gov. Murphy over confinement claims